Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients

NCT00393861 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms, Germ Cell and Embryonal

Interventions

DRUG: Bevacizumab and Oxaliplatin

Sponsor

Indiana University

Collaborators

[object Object]